CookiesThis site uses cookies to analyze site interaction in order to improve the quality of service and ensure smooth operation of the site. In more detail in Cookies policy
A specialized edition intended for medical institutions and doctors.
Treatment of infections caused by clarithromycin-sensitive microorganisms.
– Upper respiratory infections, e.g. nasopharynx (tonsillitis, pharyngitis) and sinus infections.
– Lower respiratory infections (bronchitis, acute lobar pneumonia, and primary atypical pneumonia).
– Skin and soft tissue infections (impetigo, folliculitis, erysipeloid, furunculosis, infected wounds).
– Acute and chronic odontogenic infections.
– Disseminated or localised mycobacterial infections caused by Mycobacterium avium or Mycobacterium intracellulare.Localised infections caused by Mycobacterium chelonae, Mycobacterium fortuitum or Mycobacterium kansasii.
– H. pylori eradication in patients with duodenal ulcers when hydrochloric acid secretion is inhibited (clarithromycin activity against H. pylori is higher at neutral pH than at acidic pH).
Release formThe tablet is indivisible
ChildrenAllowed from 12 years
PregnantContraindicated
Release categoryPrescription medication
DriversWith caution
Temperature storage conditionsNot higher than 25 °С